Charlotte’s Web is special strain of marijuana developed by the Stanley brothers (Joel, Jesse, Jon, Jordan, Jared and Josh) for the purposes of bringing the extremely beneficial Cannabidiol or CBD, to patients who need the therapeutic benefits of the plant, without the psychoactivity accompanied by THC. It does not induce the psychoactive “high” typically associated with recreational marijuana use. A CBD rich Cannabis Oil is extracted from the harvested plants and concentrated through rotary evaporation. To make it easier to perform clinical trials, they are planning to move the Charlotte’s Web part of their operation to Uruguay. By doing so, they will also be able to import it to any U.S. state as hemp. (source Wikipedia)
Charlotte’s Web is named after Charlotte Figi, whose parents and physicians say she experienced a significant reduction of her epileptic seizures after her first dose of medical marijuana at five years of age, and whose usage of the strain was featured in the 2013 CNN documentary “Weed”. Media coverage increased demand for Cannabis Oil and similar products high in CBD, which has been used to treat cancer and epilepsy in toddlers and children. Families who say they have run out of pharmaceutical options have moved to Colorado in order to access the strain. While the use of medical marijuana products is allowed in many U.S. states, the nationwide legal status of Cannabis Oil is less clear.
More and more we are opening our minds to the vastly superior benefits of natural healing verses profit based big pharmaceuticals. A powerful report spanning 10 years from the Centers for Disease Control and Prevention has revealed that painkillers are actually responsible for a four times as many deaths as both heroin and cocaine combined. Meanwhile the 11 largest drug companies acquired $711.4 billion in profits over the 10 years ending in 2012, according to an analysis of corporate filings by Health Care for America Now (HCAN). The global pharmaceutical industry derived much of that profit from price-gouging the Medicare Part D prescription drug program for seniors and people with disabilities.
Americans pay significantly more than any other country for the exact same drugs. In 2012 alone, the drug companies’ profits reached $83.9 billion, 62 percent higher than in 2013.